CAMALLERGY
Camallergy (Cambridge Allergy Ltd) is a biopharmaceutical company dedicated to providing innovative, patient-centric treatments to address the millions of patients suffering worldwide from food allergies. Camallergyโs lead product, CA002, is a second-generation novel oral immunotherapy for the treatment of peanut allergy designed to offer โbite-proofโ protection to patients within 14 weeks of therapy. The Companyโs unique intellectual property and treatment regimen are based on the clinical work initiated at Cambridge University Hospitals NHS Foundation Trust in Cambridge, UK.
CAMALLERGY
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.camallergy.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.92 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Amazon Pound Sterling Typekit
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovate UK
Innovate UK investment in Grant - Camallergy
Jonathan Milne
Jonathan Milne investment in Angel Round - Camallergy
Official Site Inspections
http://www.camallergy.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013